Lapatinib Terminated Phase 2 Trials for Transitional Cell Carcinoma of the Bladder / Recurrent Bladder Cancer / Metastatic Bladder Cancer / Stage III Bladder Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01382706Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder